Cargando…

SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response

Prolonged shedding of viral RNA occurs in some individuals following SARS-CoV-2 infection. We perform comprehensive immunologic evaluation of one individual with prolonged shedding. The case subject recovered from severe COVID-19 and tested positive for SARS-CoV-2 viral RNA repeatedly as many as 87...

Descripción completa

Detalles Bibliográficos
Autores principales: Turner, Jackson S., Day, Aaron, Alsoussi, Wafaa B., Liu, Zhuoming, O’Halloran, Jane A., Presti, Rachel M., Patterson, Bruce K., Whelan, Sean P. J., Ellebedy, Ali H., Mudd, Philip A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820941/
https://www.ncbi.nlm.nih.gov/pubmed/33488630
http://dx.doi.org/10.3389/fimmu.2020.618402
_version_ 1783639315826343936
author Turner, Jackson S.
Day, Aaron
Alsoussi, Wafaa B.
Liu, Zhuoming
O’Halloran, Jane A.
Presti, Rachel M.
Patterson, Bruce K.
Whelan, Sean P. J.
Ellebedy, Ali H.
Mudd, Philip A.
author_facet Turner, Jackson S.
Day, Aaron
Alsoussi, Wafaa B.
Liu, Zhuoming
O’Halloran, Jane A.
Presti, Rachel M.
Patterson, Bruce K.
Whelan, Sean P. J.
Ellebedy, Ali H.
Mudd, Philip A.
author_sort Turner, Jackson S.
collection PubMed
description Prolonged shedding of viral RNA occurs in some individuals following SARS-CoV-2 infection. We perform comprehensive immunologic evaluation of one individual with prolonged shedding. The case subject recovered from severe COVID-19 and tested positive for SARS-CoV-2 viral RNA repeatedly as many as 87 days after the first positive test, 97 days after symptom onset. The subject did not have any associated rise in anti-Spike protein antibody titers or plasma neutralization activity, arguing against re-infection. This index subject exhibited a profoundly diminished circulating CD8+ T cell population and correspondingly low SARS-CoV-2-specific CD8+ T cell responses when compared with a cohort of other recovering COVID-19 subjects. CD4+ T cell responses and neutralizing antibody responses developed as expected in this individual. Our results demonstrate that detectable viral RNA shedding in the upper airway can occur more than 3 months following infection in some individuals with COVID-19 and suggest that impaired CD8+ T cells may play a role in prolonged viral RNA shedding.
format Online
Article
Text
id pubmed-7820941
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-78209412021-01-23 SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response Turner, Jackson S. Day, Aaron Alsoussi, Wafaa B. Liu, Zhuoming O’Halloran, Jane A. Presti, Rachel M. Patterson, Bruce K. Whelan, Sean P. J. Ellebedy, Ali H. Mudd, Philip A. Front Immunol Immunology Prolonged shedding of viral RNA occurs in some individuals following SARS-CoV-2 infection. We perform comprehensive immunologic evaluation of one individual with prolonged shedding. The case subject recovered from severe COVID-19 and tested positive for SARS-CoV-2 viral RNA repeatedly as many as 87 days after the first positive test, 97 days after symptom onset. The subject did not have any associated rise in anti-Spike protein antibody titers or plasma neutralization activity, arguing against re-infection. This index subject exhibited a profoundly diminished circulating CD8+ T cell population and correspondingly low SARS-CoV-2-specific CD8+ T cell responses when compared with a cohort of other recovering COVID-19 subjects. CD4+ T cell responses and neutralizing antibody responses developed as expected in this individual. Our results demonstrate that detectable viral RNA shedding in the upper airway can occur more than 3 months following infection in some individuals with COVID-19 and suggest that impaired CD8+ T cells may play a role in prolonged viral RNA shedding. Frontiers Media S.A. 2021-01-08 /pmc/articles/PMC7820941/ /pubmed/33488630 http://dx.doi.org/10.3389/fimmu.2020.618402 Text en Copyright © 2021 Turner, Day, Alsoussi, Liu, O’Halloran, Presti, Patterson, Whelan, Ellebedy and Mudd http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Turner, Jackson S.
Day, Aaron
Alsoussi, Wafaa B.
Liu, Zhuoming
O’Halloran, Jane A.
Presti, Rachel M.
Patterson, Bruce K.
Whelan, Sean P. J.
Ellebedy, Ali H.
Mudd, Philip A.
SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response
title SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response
title_full SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response
title_fullStr SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response
title_full_unstemmed SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response
title_short SARS-CoV-2 Viral RNA Shedding for More Than 87 Days in an Individual With an Impaired CD8+ T Cell Response
title_sort sars-cov-2 viral rna shedding for more than 87 days in an individual with an impaired cd8+ t cell response
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7820941/
https://www.ncbi.nlm.nih.gov/pubmed/33488630
http://dx.doi.org/10.3389/fimmu.2020.618402
work_keys_str_mv AT turnerjacksons sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT dayaaron sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT alsoussiwafaab sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT liuzhuoming sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT ohalloranjanea sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT prestirachelm sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT pattersonbrucek sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT whelanseanpj sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT ellebedyalih sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse
AT muddphilipa sarscov2viralrnasheddingformorethan87daysinanindividualwithanimpairedcd8tcellresponse